Allogeneic Disc Progenitor Cells Safely Increase Disc Volume and Improve Pain, Disability, and Quality of Life in Patients With Lumbar Disc Degeneration-Results of an FDA-Approved Biologic Therapy Randomized Clinical Trial.
Matthew F GornetDouglas P BeallTimothy T DavisDomagoj CoricMichael LaBagnaraAngela KrullMichael J DePalmaPatrick C HsiehSrinivas MallempatiFrancine W SchranckColleen KellyKevin T FoleyPublished in: International journal of spine surgery (2024)
NCT03347708-Study to Evaluate the Safety and Preliminary Efficacy of Injectable Disc Cell Therapy, a Treatment for Symptomatic Lumbar Intervertebral Disc Degeneration.